Key result
EPA specifically attenuates cardiomyocyte responses to multiple GPCR autoantibodies.
Why the study?
Because ischemia and inflammation may act as cofactors modulating the functional activity of GPCR autoantibodies, this study aimed to examine the influence of arachidonic acid, eicosapentaenoic acid, and ciliary neurotrophic factor on cardiomyocyte responses to GPCR agonists and GPCR-fAAbs.
Lipid mediators such as AA and EPA, as well as the inflammatory cytokine CNTF, can modulate the functional responses of cardiomyocytes to GPCR-targeting autoantibodies.
Autoantibodies (AAbs) play an important role in the development of autoimmune diseases. While many AAbs induce apoptosis of target cells, a distinct subgroup, termed functional autoantibodies (fAAbs) against G protein–coupled receptors (GPCRs), can modulate physiological receptor signaling without inducing cell death. The functional activity of GPCR-fAAbs may be influenced by various cofactors, including inflammation (e.g., inflammatory cytokine, ciliary neurotrophic factor (CNTF)) and ischemia. As ischemia triggers a substantial release of arachidonic acid (AA) from membrane phospholipids, the present study aimed to examine exploratively the influence of AA, eicosapentaenoic acid (EPA), and CNTF on the responses of spontaneously beating neonatal rat cardiomyocytes to GPCR agonists and GPCR-fAAbs. AA and EPA differentially influenced responses in cardiomyocytes induced by GPCR-fAAbs: AA altered the functional responses associated with adrenergic β2-fAAb, adrenergic α1-fAAb, angiotensin II (AT1)-fAAb, endothelin A (ETA)-fAAb and angiotensin 1–7 MAS-fAAbs. However, muscarinergic M2-fAAb responses remained largely unaffected. In contrast, EPA attenuated the responses to β2-fAAb, α1-fAAb, AT1-fAAb, and ETA-fAAb, while MAS-fAAb and M2-fAAb responses were not markedly altered. CNTF acted as a time-dependent modulator of cardiomyocyte chronotropic responses and influenced the magnitude of GPCR-mediated signaling on a cardiomyocyte bioassay. Together, these findings might suggest that lipid mediators such as AA and EPA or CNTF may modulate functional responses of cardiomyocytes associated with GPCR-fAAbs.
No takes yet. Share an insight, caveat, or question.
Wallukat et al. (2026) studied this question. Arachidonic acid, eicosapentaenoic acid (EPA), and CNTF differentially modulate cardiomyocyte responses to GPCR autoantibodies, with EPA specifically attenuating multiple fAAb responses.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: